A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia (vol 101, pg 2413, 2022)
第一作者单位：[1]Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Canc Personalized Med, Dept Hematol,Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing, Jiangsu, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Jin Yuanyuan,Li Ruixin,Lin Shengyun,et al.A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia (vol 101, pg 2413, 2022)[J].ANNALS OF HEMATOLOGY.2023,102(2):501-501.doi:10.1007/s00277-023-05107-7.
APA：
Jin, Yuanyuan,Li, Ruixin,Lin, Shengyun,Jia, Jinsong,Yang, Yan...&Li, Jiangyong.(2023).A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia (vol 101, pg 2413, 2022).ANNALS OF HEMATOLOGY,102,(2)
MLA：
Jin, Yuanyuan,et al."A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia (vol 101, pg 2413, 2022)".ANNALS OF HEMATOLOGY 102..2(2023):501-501
